GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report) crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.00 and traded as high as $0.00. GB Sciences shares last traded at $0.00, with a volume of 15,815 shares trading hands.
GB Sciences Stock Performance
About GB Sciences
GB Sciences, Inc, a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs.
Further Reading
- Five stocks we like better than GB Sciences
- Financial Services Stocks Investing
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- 3 Small Caps With Big Return Potential
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- The Most Important Warren Buffett Stock for Investors: His Own
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
